These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28278299)

  • 1. Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
    Haglund S; Vikingsson S; Almer S; Söderman J
    PLoS One; 2017; 12(3):e0173825. PubMed ID: 28278299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
    J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis.
    de Boer YS; van Gerven NM; de Boer NK; Mulder CJ; Bouma G; van Nieuwkerk CM
    Aliment Pharmacol Ther; 2013 Mar; 37(6):640-6. PubMed ID: 23347359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
    Hoentjen F; Hanauer SB; de Boer NK; Rubin DT
    Dig Dis Sci; 2012 Jan; 57(1):250-3. PubMed ID: 22147254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia.
    Kamojjala R; Bostrom B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):95-100. PubMed ID: 33750748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of intravenously administered high-dose 6-mercaptopurine with and without allopurinol treatment in patients with non-Hodgkin lymphoma.
    Keuzenkamp-Jansen CW; DeAbreu RA; Bökkerink JP; Lambooy MA; Trijbels JM
    J Pediatr Hematol Oncol; 1996 May; 18(2):145-50. PubMed ID: 8846126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of allopurinol induced TPMT inhibition.
    Blaker PA; Arenas-Hernandez M; Smith MA; Shobowale-Bakre EA; Fairbanks L; Irving PM; Sanderson JD; Marinaki AM
    Biochem Pharmacol; 2013 Aug; 86(4):539-47. PubMed ID: 23770457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Seinen ML; van Asseldonk DP; de Boer NK; Bouma G; van Nieuwkerk CM; Mulder CJ; Bloemena E; van Bodegraven AA
    Inflamm Bowel Dis; 2017 Mar; 23(3):448-452. PubMed ID: 28151736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC; Muktar H; Effken C; Mahajan PB
    Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
    Zhang M; Bostrom B
    F1000Res; 2019; 8():176. PubMed ID: 30828444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
    Smith MA; Blaker P; Marinaki AM; Anderson SH; Irving PM; Sanderson JD
    J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
    Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Barnes A; Ooi SJ; Lynch KD; Parthasarathy N; Bishara M; Gounder M; Grafton R; Leach P; Bampton P; Sechi A; Ng W; Connor S; van Langenberg D; Mountifield R; Andrews JM
    Dig Dis Sci; 2023 Mar; 68(3):889-896. PubMed ID: 35687221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
    Broekman MM; Roelofs HM; Wong DR; Kerstholt M; Leijten A; Hoentjen F; Peters WH; Wanten GJ; de Jong DJ
    Cell Biol Toxicol; 2015 Jun; 31(3):161-71. PubMed ID: 25916701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?
    Haglund S; Almer S; Peterson C; Söderman J
    PLoS One; 2013; 8(2):e56989. PubMed ID: 23437289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH
    Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.